Compositions and methods for viral sensitization
US-2024360115-A1 · Oct 31, 2024 · US
Clostridium perfringens bacteriophage Clo-PEP-1 and use thereof for inhibiting proliferation of clostridium perfringens
US10028984B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10028984-B2 |
| Application number | US-201515538252-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2015 |
| Priority date | Dec 29, 2014 |
| Publication date | Jul 24, 2018 |
| Grant date | Jul 24, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a Myoviridae bacteriophage Clo-PEP-1 that is isolated from the nature and can kill Clostridium perfringens cells specifically, which has the genome represented by nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12664BP), and a method for preventing and treating the infections of Clostridium perfringens cells using the composition comprising said bacteriophage as an active ingredient.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for preventing or treating a Clostridium perfringens infection, which comprises a step of administering to a subject a composition comprising Myoviridae bacteriophage Clo-PEP-1, wherein said bacteriophage comprises the nucleotide sequence of SEQ ID NO: 1 as an active ingredient. 2. The method for preventing or treating a Clostridium perfringens infection according to claim 1 , wherein the composition is administered to a subject in the form of a feed additive, a drinking water additive, or a disinfectant.
Assignees
Inventors
Classifications
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent · CPC title
Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title
- C12N7/00Primary
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Demonstrated in vivo effect · CPC title
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10028984B2 cover?
- The present invention relates to a Myoviridae bacteriophage Clo-PEP-1 that is isolated from the nature and can kill Clostridium perfringens cells specifically, which has the genome represented by nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12664BP), and a method for preventing and treating the infections of Clostridium perfringens cells using the composition comprising said bacter…
- Who is the assignee on this patent?
- Intron Biotechnology Inc
- What technology area does this patent fall under?
- Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).